Effect of 2 mg versus 4 mg of intravenous zoledronic acid on bone mineral density at the lumbar Spine in Indian postmenopausal women with osteoporosis: A Double-blind parallel-arm randomized controlled trial
Objective: The primary purpose was to compare the effect of 2 mg and 4 mg of intravenous zoledronic acid (ZA) on change in the lumbar spine (LS) bone mineral density (BMD) at the end of 1 year in postmenopausal women with osteoporosis. The secondary objectives were changes in BMD at the total hip an...
Saved in:
Main Authors: | Harsh Durgia (Author), Sadishkumar Kamalanathan (Author), Govindarajalou Ramkumar (Author), Sonali Sarkar (Author), Sagili Vijaya Bhaskar Reddy (Author), Jayaprakash Sahoo (Author), Rajan Palui (Author), Henith Raj (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
by: F. Bertoldo, et al.
Published: (2011) -
Chordoma Of Lumbar Spine
by: Nirmala M.J.*, H.A. Parshwanath and A.M.Patil
Published: (2010) -
Clinical anatomy of the lumbar spine and sacrum
by: Trish Wallner-Schlotfeldt
Published: (2000) -
The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007) -
A single-dose, randomized, open-labeled, parallel-group study comparing the pharmacokinetics, pharmacodynamics and safety of leuprolide acetate microspheres 3.75 mg and Enantone® 3.75 mg in healthy male subjects
by: Xingjiang Hu, et al.
Published: (2022)